Bayer Schering Pharma (Logo)
The Bayer Cross
  • >> Bayer Group
  • Sitemap
  • RSS
  • Contact us
Home
  • Company
    • Our Biotech Leadership
    • Corporate Social Responsibility
    • Locations
    • Bayer AG
  • Products
    • About Betaseron®
    • About Kogenate®
  • Biological Development
    • Key Development Projects
  • Innovation Center
    • Research Groups
  • Biomanufacturing
    • Berkeley
    • Emeryville
    • Seattle
  • Partnering
    • Opportunities
  • Careers
    • Current Openings
    • Benefits
    • Diversity
    • Internships
  • Newsroom
    • Media Contacts
    • RSS
    • News
  • Products
  • About Betaseron®
    • About MS
  • About Kogenate®
Country Links

Bayer Links
  • Bayer Global
  • Bayer HealthCare Global
  • Investor Relations
  • General Conditions of Use
  • Privacy Statement
  • Imprint

Copyright ©
Bayer HealthCare

About Betaseron®

The Bayer Emeryville supply center manufactures Betaseron®*, a medication approved for the treatment of relapsing forms of MS to reduce the frequency of relapses. Betaseron is the only high dose, high frequency interferon-beta FDA-approved for treatment at the first MS event.

BETASERON® is believed to help fight relapsing forms of MS in the following ways:

  • It blocks certain immune system cells — called T cells — from attacking myelin, the material that protects axons
  • It stops certain types of proteins from activating the immune system

Treatment with BETASERON® cannot restore lost function, but it may slow future disease progression.

* BETASERON® (Interferon beta-1b) Prescribing Information.


Betaseron logo

Related Links:

  • Betaseron Website
  • Betaseron's MS website for patients
Font size
-+ Font Sizer Control

click to adjust

Page tools
  • Printer friendly version
  • Bookmark this page
  • Email Us
Search